Search

everythinglearnresearchcommunity

for

Search:↓

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

JAK inhibitors might help treat alopecia areata.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Tiny particles from skin cells can help activate hair growth.

Skin bacteria can help wound healing by activating certain immune cells.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

FOXN1 gene variants cause low T cells and immune issues from birth.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.